https://adisinsight.springer.com/trials/700390976?error=cookies_not_supported&code=d49fbb6e-3142-4915-b5e0-e7050a6c0aa8
Abemaciclib Combined With FOLFOX/FOLFIRI Regimen in Patients With Advanced Colorectal Liver...
This is a single-center, single-arm, open-label clinical study, to explore the efficacy and safety of abemaciclib combined with FOLFOX/FOLFIRI regimen in
in patientsabemaciclibcombinedfolfoxfolfiri
https://pubmed.ncbi.nlm.nih.gov/34066784/
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic...
Nab-FOLFIRI and Nab-FOLFOX might be hopeful first-line CT options for mPC patients, with promising activity and a good safety profile.
https://pubmed.ncbi.nlm.nih.gov/24330513/
FOLFIRI as a second-line therapy in patients with docetaxel-pretreated gastric cancer: a historical...
FOLFIRI appears an effective and safe treatment option for pretreated metastatic gastric cancer patients, and deserves further investigation in randomized...
https://pubmed.ncbi.nlm.nih.gov/39002347/
A randomized phase II trial of Captem or Folfiri as second-line therapy in neuroendocrine carcinomas
https://www.cancerresearchuk.org/about-cancer/treatment/drugs/aflibercept-folfiri
Aflibercept and folinic acid, fluorouracil and irinotecan (FOLFIRI) | Cancer Research UK
Aflibercept and folinic acid, fluorouracil, and irinotecan (FOLFIRI) is a cancer drug combination. It is a treatment for some people with colorectal cancer...
folinic acidcancer researchafliberceptfluorouracilirinotecan
https://pubmed.ncbi.nlm.nih.gov/19406901/?dopt=Abstract
Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in...
The BEAT study shows that the efficacy and safety profile of bevacizumab in routine clinical practice is consistent with results observed in prospective...
safety and efficacy